格隆汇9月17日丨昊海生物科技(06826.HK)发布公告，2025年9月17日耗资51.52万港元回购1.84万股，回 购价格每股28港元。 ...

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 上海昊海生物科技股份有限公司（於中華人民共和國註冊成立的股份有限公司） 呈交日期： 2025年9月17日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | H | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 06826 | 說明 | H 股 | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | 庫存股份變動 | | | | | 事件 ...

红星资本局9月17日消息，玻尿酸巨头昊海生科（688366.SH）昨日晚间公告称，公司控股股东、实际控制人之一蒋伟收到中国证监会出具的《行政处罚事 先告知书》，处罚的原因为涉嫌内幕交易。 昊海生科强调，此次处罚是针对蒋伟个人，涉及的事项与公司无关。 据了解，昊海生科虽然由蒋伟创立，但其本人长期退居幕后，几乎不参与公司经营。不过，蒋伟设立的股权体系使之牢牢掌握昊海生科的控制权，上市6年 间，蒋伟从昊海生科获得分红超2.5亿元。 9月17日，红星资本局拨打昊海生科董秘办电话，但截至发稿未能接通。此前，昊海生科董事长侯永泰在接受采访时表示，蒋伟就是一个投资人，喜欢做股 票，但操作的并不是昊海生科的股票。 资料图 图据视觉中国 资料显示，昊海生科是一家专注于研发、生产及销售医用生物材料的高科技生物医药企业，系国内知名的玻尿酸生产商。 昊海生科最早起源于蒋伟创立的昊海有限。2007年5月，上海华源松江分公司相关资产被注入到昊海有限，为该公司进入玻尿酸领域打下基础，侯永泰也是 此时和蒋伟产生联系。2009年，侯永泰接任昊海有限董事长职位，并一直持续至今，而蒋伟退居幕后，再未在公司任职。 2019年，昊海生科登陆上交所，此 ...

Group 1 - The Ministry of Commerce and eight other departments issued 19 specific measures to expand service consumption, focusing on enhancing service quality and promoting consumer activities [1] - The "Service Consumption Quality Improvement and Benefit Action" plan was introduced to strengthen policy support, build platforms, and optimize the consumption environment [1] - The initiative includes the continuous development of the "Buy in China" brand and the launch of a series of promotional activities in key service sectors [1] Group 2 - The Chinese Ministry of National Defense confirmed that the Fujian aircraft carrier is conducting sea trials, which is a normal part of its construction process [2] - The development of the aircraft carrier is aligned with national security needs and technological advancements, emphasizing China's commitment to a defensive national policy [2] - The Fujian carrier is expected to play a significant role in safeguarding national sovereignty and development interests [2] Group 3 - The China National Medical Products Administration released the first industry standard for medical devices using brain-computer interface technology, set to take effect on January 1, 2026 [4] - This standard aims to support the high-quality development of the brain-computer interface medical device industry [4] Group 4 - The Shenzhen Securities Regulatory Bureau issued a warning letter to Qianhai Hongtai Fund Management Co., Ltd. for failing to complete fund filing procedures after fundraising [5] - This action is based on violations of the Private Fund Management Regulations [5] Group 5 - Vanke A received a loan of up to 2.064 billion yuan from Shenzhen Metro Group [8] - Hengwei Technology plans to acquire 75% of Shuheng Technology's shares, leading to a stock suspension [8] - Shanghai Construction's stock has seen significant short-term gains, indicating potential market overheating [8] - Huohai Biotechnology's controlling shareholder received an administrative penalty notice [8] - Funeng Technology plans to mass-produce its third-generation semi-solid battery by 2026 [8] - Luxiao Technology signed an AI robot cooperation agreement with its subsidiary [8] - Haon Electric received a product designation notice, estimating total revenue of approximately 2.477 billion yuan over its lifecycle [8] - Haowei Group has entered NVIDIA's supply chain [8] - AVIC Optoelectronics has shipped UQD connectors and liquid cooling pipe components to overseas manufacturers [8]

Group 1 - The core point of the article is that Haohai Biological Technology has received a notice from the China Securities Regulatory Commission regarding an administrative penalty, which pertains to its controlling shareholder Jiang Wei, and is unrelated to the company's operations [1] - The company stated that Jiang Wei does not participate in daily management, and the matter will not have a significant impact on the company's daily operations, business, or financials [1]

每经记者｜陈晴 每经编辑｜程鹏 张喜威 王晓波 ~~~文末有福利~~~ 标题点睛： 9月16日，有消息称，在长春航展现场两架小鹏汇天eVTOL（电动垂直起降器）相撞后坠机。对此，小鹏汇天方面回应称："9月16日下午，广东汇天通航 在长春航展预演结束后，参与双机编队演练的两架飞行器因飞行间距不足发生接触。 1 隔夜市场 美股三大指数集体收跌，道指跌0.27%，标普500指数跌0.13%，纳斯达克综合指数跌0.07%；大型科技股涨跌互现，特斯拉涨超2%，甲骨文涨超1%，微 软、英伟达跌超1%。中概股多数上涨，纳斯达克中国金龙指数涨1.76%，创下自2022年2月以来新高；蔚来涨超8%，百度涨超7%，京东、爱奇艺涨超 3%，阿里巴巴涨超2%。 国际贵金属期货收盘涨跌不一，COMEX黄金期货涨0.23%，报3727.5美元/盎司；COMEX白银期货跌0.19%，报42.88美元/盎司。 国际油价强势上扬，美油主力合约收涨1.97%，报64.55美元/桶；布伦特原油主力合约涨1.59%，报68.51美元/桶。 欧洲三大股指收盘全线下跌，德国DAX指数跌1.77%报23329.24点，法国CAC40指数跌1%报7818. ...

Industry News - The Ministry of Commerce and nine other departments released policies to expand service consumption, including a series of promotional activities and optimizing operational hours for popular cultural and tourist venues [2][3] - The Ministry of Industry and Information Technology issued guidelines for the digital transformation of key industries, providing scenario maps for 14 sectors including steel, petrochemicals, and new energy vehicles [2][3] - The National Medical Products Administration approved the first medical device standard for brain-computer interface technology, set to be implemented on January 1, 2026 [2] - The People's Bank of China stated that the CIPS cross-border payment system has become a crucial support for the internationalization of the Renminbi [2] Company News - Tianpu Co. announced that the acquisition funds of 9.65 billion yuan from Zhonghao Xinying have been received [3][13] - Haowen Automotive announced a significant contract worth approximately 24.77 billion yuan for ADAS perception systems and radar systems [7] - Luxiao Technology plans to launch a family AI service robot, aiming to sell at least 1 million units in the US and European markets by 2026-2028 [8] - Tianqi Lithium stated that its pilot project for producing 50 tons of lithium sulfide has commenced [9] - Hangke Technology announced a share transfer price of 28.61 yuan per share, at a 20% discount to the closing price [10] - Brother Technology expects a year-on-year net profit increase of 207%-253% for the first three quarters of 2025 [13] Investment Opportunities - The humanoid robot industry is anticipated to enter a sales growth phase, with expectations for significant advancements and market readiness by 2026 [15] - Nvidia is requesting suppliers to develop new micro-channel liquid cooling plate (MLCP) technology due to increased power consumption of its new AI platforms, indicating a shift in cooling technology requirements [16]

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：688366 证券简称：昊海生科 公告编号：2025-042 上海昊海生物科技股份有限公司 行政处罚最终结果将以中国证监会对蒋伟先生最终出具的《行政处罚决定书》结论为准。公司将持续关 注上述事项的进展情况，并按照有关法律法规的规定和要求，及时履行信息披露义务，敬请广大投资者 注意投资风险。 特此公告。 上海昊海生物科技股份有限公司董事会 2025年9月17日 收到《行政处罚事先告知书》的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性依法承担法律责任。 上海昊海生物科技股份有限公司（以下简称"公司"）控股股东、实际控制人之一蒋伟先生于2025年5月 收到中国证券监督管理委员会（以下简称"中国证监会"）出具的《立案告知书》（编号：证监立案字 0382025016 号）。因其涉嫌内幕交易，根据《中华人民共和国证券法》《中华人民共和国行政处罚 法》等法律法规，中国证监会决定对其立案。具体内容详见公司于2025年5月8日披露的《上海昊海生物 科技股份有限公司关于控股股东、实际控制人之一 ...

Core Viewpoint - Several listed companies in the Shanghai and Shenzhen stock markets announced significant developments, including financing arrangements, asset sales, and strategic partnerships, which may present investment opportunities and risks for investors [4][5][6][8][9][10]. Financing and Borrowing - Vanke A announced that its largest shareholder, Shenzhen Metro Group, will provide a loan of up to 2.064 billion yuan to repay bond principal and interest, with a loan term of no more than three years and a floating interest rate based on the LPR minus 66 basis points [4]. - Jianfeng Group obtained a loan commitment of up to 36 million yuan from China Merchants Bank for stock repurchase, with a loan term of no more than 36 months at an interest rate of 1.8% [11]. Asset Sales and Acquisitions - Angli Education plans to sell 100% of Kensington Park School Limited for 80,000 pounds (approximately 760,100 yuan) to alleviate financial pressure [5]. - Guang'an Aizhong intends to acquire 90% of Qitai Hengtai at a price of 0 yuan, with plans for further investment in renewable energy projects [12][13]. - Suzhou Planning aims to acquire 80% of Kunshan Development Zone Architectural Design Institute for 831,720 yuan [18]. Regulatory and Compliance Issues - Haohai Biotechnology's controlling shareholder received an administrative penalty notice from the CSRC for suspected insider trading, although it is stated that this will not significantly impact the company's operations [7]. - Yunding Technology received a warning letter from the Shandong Securities Regulatory Bureau for inaccurate financial disclosures in its 2015 annual report [8]. Performance and Forecasts - Brothers Technology expects a net profit of 100 million to 115 million yuan for the first three quarters of 2025, representing a year-on-year increase of 207.32% to 253.42%, driven by rising prices of certain vitamin products and improved production efficiency [21]. Strategic Partnerships and Contracts - Jiuzhou Yiqu signed a strategic cooperation agreement with China Electric Power Construction Group Chengdu Survey and Design Institute to enhance collaboration in the rail transit sector [22]. - Luxiao Technology's subsidiary signed a strategic cooperation agreement to develop AI service robots for the US and European markets, aiming to sell at least 1 million units by 2026-2028 [23]. - China Shipbuilding Technology signed a green methanol sales contract worth approximately 40 million USD per year, with potential increases based on customer demand [24]. Stock Transactions and Shareholder Actions - Several companies, including Maidi Technology and Xin Hua Co., announced plans for shareholders to reduce their stakes, with reductions ranging from 1.7% to 3% of total shares [29][30][31][34][35].

每经编辑｜黄胜 9月16日，昊海生科（688366.SH）公告称，公司控股股东、实际控制人之一蒋伟于2025年5月收到中国证监会出具的《立案告知书》。因其涉嫌内幕交易， 中国证监会决定对其立案。近日，公司收到蒋伟通知，获悉其收到中国证监会出具的《行政处罚事先告知书》。该《行政处罚事先告知书》所涉主体为蒋伟 个人，涉及的事项与公司无关。蒋伟不参与公司日常经营管理，该事项不会对公司日常经营、业务及财务造成重大影响。 图片来源：视觉中国-VCG211322973159 | | | | 前 10 名股东持股情况(不含通过转融通出借股份) | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 股东名称 | 股东性质 | 持股数量 | 持股比 例(%) | 持有有 限售条 | 包含转融通 借出股份的 | 质押、标记或冻结 情况 | | | | | | | 件股份 | 限售股份数 | 股份状 | | | | | | | 数量 | 喜 | 不 | 数量 | | 将伟 | 境内自然人 | 66,528,000 | 28.53 | 0 | 0 | 元 | 0 ...